Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Becatecarin in Children With Solid Tumors
NCT00006102Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2000
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 2, open-label, single-arm trial of becatecarin in solid tumor and non-Hodgkin lymphoma (NHL), sponsored by National Cancer Institute. Primary endpoint: Objective Response Rate. Started Jul 2000; status: completed.
02
Drugs
becatecarin
03
Conditions
solid tumornon-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00006102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006102.